186 related articles for article (PubMed ID: 35581263)
21. Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Zhou J; Xu L; Zhou H; Wang J; Xing X
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510286
[TBL] [Abstract][Full Text] [Related]
22. SERPINB7 as a prognostic biomarker in cervical cancer: Association with immune infiltration and facilitation of the malignant phenotype.
Wei HF; Zhang RF; Zhao YC; Tong XS
Heliyon; 2023 Sep; 9(9):e20184. PubMed ID: 37809412
[TBL] [Abstract][Full Text] [Related]
23. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
24. MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma.
Song L; Liu S; Yao H; Zhang L; Li Y; Xu D; Li Q
Biomed Pharmacother; 2019 Jul; 115():108944. PubMed ID: 31082771
[TBL] [Abstract][Full Text] [Related]
25. Effects of RNA Modification "Writers" of GALNT2 on the Tumor Microenvironment in Cervical Squamous Cell Carcinoma.
Wang S; Chen L
J Environ Pathol Toxicol Oncol; 2022; 41(4):25-38. PubMed ID: 36374960
[TBL] [Abstract][Full Text] [Related]
26. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
Liu C; Zhang M; Yan X; Ni Y; Gong Y; Wang C; Zhang X; Wan L; Yang H; Ge C; Li Y; Zou W; Huang R; Li X; Sun B; Liu B; Yue J; Yu J
Sci Adv; 2023 Jan; 9(4):eadd8977. PubMed ID: 36706185
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
29. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Li J; Xi J
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
[TBL] [Abstract][Full Text] [Related]
30. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
Pan XB; Lu Y; Huang JL; Long Y; Yao DS
Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
[TBL] [Abstract][Full Text] [Related]
31. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract][Full Text] [Related]
32. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment.
Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X
Front Immunol; 2022; 13():888650. PubMed ID: 35572541
[TBL] [Abstract][Full Text] [Related]
33. Prognosis, immune microenvironment, and personalized treatment prediction in Rho GTPase-activating protein 4-mutant cervical cancer: Computer strategies for precision oncology.
Lu X; Ying Y; Zhang W; Zhang J; Li R; Wang W
Life Sci; 2023 Feb; 315():121360. PubMed ID: 36608869
[TBL] [Abstract][Full Text] [Related]
34. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
[TBL] [Abstract][Full Text] [Related]
35. The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma.
Gao L; Chen R; Sugimoto M; Mizuta M; Kishimoto Y; Omori K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638642
[TBL] [Abstract][Full Text] [Related]
36. ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma.
Liu S; Geng R; Lin E; Zhao P; Chen Y
Front Genet; 2021; 12():602160. PubMed ID: 33732282
[TBL] [Abstract][Full Text] [Related]
37. Construction of prognosis model of pyroptosis gene and characterization of tumor microenvironment infiltration in cervical cancer.
Zhang M; Wu P
Medicine (Baltimore); 2022 Nov; 101(46):e31599. PubMed ID: 36401372
[TBL] [Abstract][Full Text] [Related]
38. ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.
Humtsoe JO; Pham E; Louie RJ; Chan DA; Kramer RH
Oncogene; 2016 Mar; 35(12):1554-64. PubMed ID: 26073080
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.
Mandai M; Konishi I; Koshiyama M; Komatsu T; Yamamoto S; Nanbu K; Mori T; Fukumoto M
Cancer; 1995 May; 75(10):2523-9. PubMed ID: 7736397
[TBL] [Abstract][Full Text] [Related]
40. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Ke J; Cui J; Yang X; Du X; Ma B; Yu L
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
